Hydrogenated Fat Composition TEQ Control via Low-Temperature Processing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current processes for modifying vegetable oils, such as palm oil, using hydrogenation at high temperatures lead to the conversion of less toxic octachlorodibenzodioxin (OCDD) into more toxic, less chlorinated dioxins, increasing the toxic equivalent value (TEQ) of the resulting composition, and require costly activated carbon for purification.
Innovation Solution
Hydrogenating unsaturated fat compositions at a temperature of 140°C or lower with a catalyst and hydrogen source to partially hydrogenate the fats while preventing dechlorination of OCDD, thereby maintaining or reducing the TEQ value within acceptable levels without the need for activated carbon.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If hydrogenation is performed at high temperatures to increase saturated fatty acid content, then the hydrogenation efficiency is improved, but the dechlorination of OCDD occurs converting it to more toxic dioxins, increasing the TEQ value
Solution Approach 1:
The patent changes the temperature parameter from conventional high temperatures (typically 150-200°C) to a lower temperature range (100-140°C). This parameter change allows the hydrogenation reaction to proceed at reduced intensity, preventing the dechlorination of OCDD while still achieving adequate hydrogenation of unsaturated fatty acids. The lower temperature is the key parameter modification that resolves the contradiction between hydrogenation efficiency and TEQ value control.
2Manufacturing precision
If activated carbon is used to remove PCDDs and reduce TEQ value, then the purity of the fat composition is improved, but the process cost and purification time increase
Solution Approach 1:
The patent applies preliminary action by controlling the hydrogenation temperature to prevent the formation of toxic dioxins in the first place, rather than relying on subsequent purification steps to remove them. By maintaining temperature at 100-140°C during hydrogenation, OCDD remains stable and does not convert to more toxic compounds, thereby preemptively addressing the purity issue without requiring activated carbon treatment or extended purification procedures.
3Object-affected harmful factors
If activated carbon is used to adsorb PCDDs, then the TEQ value is reduced, but the process complexity and cost increase
Solution Approach 1:
The patent converts the potential harm of OCDD dechlorination into a benefit by controlling reaction conditions that preserve OCDD stability. Instead of viewing OCDD as a contaminant to be removed, the approach leverages its stability at lower temperatures to prevent the formation of more toxic dioxins. This transforms the challenge of dealing with PCDDs into an advantage where the controlled environment prevents harmful transformations entirely.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively increases saturated fatty acid content while maintaining or reducing the TEQ value of the hydrogenated fat composition, ensuring it remains within 60% of the unsaturated fat composition's TEQ value, and avoids the costly purification steps associated with activated carbon.
Implementation Method 1
contacting the unsaturated fat composition with a catalyst and a hydrogen source at a temperature of 140°C or lower to at least partially hydrogenate the unsaturated fat composition
Implementation Method 2
contacting the unsaturated fat composition with a catalyst and a hydrogen source
Data Source
AI summary
A process for the preparation of a hydrogenated fat composition comprises the steps of: i) providing an unsaturated fat composition comprising unsaturated fatty acids and/or unsaturated fatty acid residues, wherein the unsaturated fat composition comprises polychlorodibenzodioxins (PCDDs) including octachlorodibenzodioxin (OCDD); and ii) contacting the unsaturated fat composition with a catalyst and a hydrogen source at a temperature of about 170°C or lower to at least partially hydrogenate the unsaturated fat composition.
